✦ LIBER ✦

Colorectal cancer pharmacogenomics

✍ Scribed by Sharon Marsh; Jinsheng Yu; Janelle M. Hoskins

Book ID: 107535634
Publisher: Current Science Inc.
Year: 2006
Tongue: English
Weight: 139 KB
Volume: 2
Category: Article
ISSN: 1556-3790
DOI: 10.1007/s11888-006-0026-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cancer pharmacogenomics: international t

Cancer pharmacogenomics: international trends

✍ Yasuko Yamayoshi; Emiko Iida; Yusuke Tanigawara 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 434 KB

Identification of potential pharmacogeno

Identification of potential pharmacogenomic markers of clinical efficacy of 5-fluorouracil in colorectal cancer

✍ Stefania Nobili; Cristina Napoli; Ida Landini; Maria Morganti; Fabio Cianchi; Ro 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 450 KB

## Abstract Although adjuvant chemotherapy has significantly increased overall survival in resected Stage III colorectal cancer, disease recurrence is still high (30–40%). 20–25% of Stage II patients also develop recurrent disease. Thus, high‐risk patients may benefit from chemotherapy. As patient

Cancer pharmacogenomics: achievements in

Cancer pharmacogenomics: achievements in basic research

✍ Miki Nakajima; Tsuyoshi Yokoi 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 201 KB

Pharmacogenomics in colorectal carcinoma

Pharmacogenomics in colorectal carcinomas: Future perspectives in personalized therapy

✍ Antonio Russo; Simona Corsale; Patrizia Cammareri; Valentina Agnese; Sandra Casc 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 207 KB

## Abstract The recent introduction of new drugs such as capecitabine, irinotecan, and oxaliplatinum has greatly improved the clinical outcome of patients with advanced/metastatic colorectal cancer. Nevertheless, some patients may suffer from the adverse drug reactions which will probably be the ma

Colorectal cancer

✍ P. W. J. Houghton; N. J. McC. Mortensen 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 1 views

## Ornithine decarboxylase as a marker for colorectal adenomas Sir I was interested to read the paper by Moorehead and colleagues (Br J Surg 1987; 74: 3645). In their discussion the authors state that the finding of diminished levels of ornithine decarboxylase in macroscopically normal rectal muco

Cancer Colorectal

✍ René Lambert 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 French ⚖ 92 KB